• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biofrontera Inc. - Common Stock (NQ:BFRI)

0.9303 -0.0557 (-5.65%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Biofrontera Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025
May 06, 2025
Via ACCESS Newswire
News headline image
Biofrontera Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
December 03, 2024
Via ACCESSWIRE
News headline image
Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024
November 01, 2024
Via ACCESSWIRE
News headline image
Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference
September 25, 2024
Via ACCESSWIRE
News headline image
Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024
August 09, 2024
Via ACCESSWIRE
News headline image
Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update
May 15, 2024
Via ACCESSWIRE
News headline image
CORRECTION: Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
March 15, 2024
Via ACCESSWIRE
News headline image
Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
March 15, 2024
Via ACCESSWIRE
News headline image
Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024
May 06, 2024
Via ACCESSWIRE
News headline image
Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants
May 03, 2024
Via ACCESSWIRE
News headline image
Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals
March 26, 2024
Via ACCESSWIRE
News headline image
Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024
March 08, 2024
Via ACCESSWIRE
BioMedNewsBreaks – Biofrontera Inc. (NASDAQ: BFRI) Closes on Private Placement Valued at Up to $16M
March 04, 2024
Via Investor Brand Network
News headline image
Biofrontera Inc. Reports Third Quarter 2023 Financial Results and Provides a Business Update
November 09, 2023
Via ACCESSWIRE
News headline image
Biofrontera Inc. Receives FDA Approval for New Formulation of Ameluz(R)
October 10, 2023
Via ACCESSWIRE
News headline image
Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules
February 23, 2024
Via ACCESSWIRE
News headline image
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG
February 20, 2024
Via ACCESSWIRE
News headline image
Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules
February 20, 2024
Via ACCESSWIRE
News headline image
Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz(R) to Permit Up to Three Tubes Per Use
February 05, 2024
Via ACCESSWIRE
News headline image
Biofrontera Inc. Announces Preliminary Third Quarter Revenues
October 04, 2023
Via ACCESSWIRE
News headline image
Biofrontera Inc. Reports Second Quarter 2023 Financial Results and Provides a Business Update
August 11, 2023
Via ACCESSWIRE
News headline image
Biofrontera Inc. Announces Last Patient Enrolled in Phase 3 Clinical Study Evaluating Ameluz(R)-PDT for the Treatment of Basal Cell Carcinoma
August 10, 2023
Via ACCESSWIRE
News headline image
Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2023
January 11, 2024
Via ACCESSWIRE
BioMedNewsBreaks – Biofrontera Inc. (NASDAQ: BFRI) Announces $4.5M Registered Direct
November 21, 2023
Via Investor Brand Network
News headline image
Biofrontera Inc. to Report Third Quarter 2023 Financial Results on November 9 and Hold Conference Call on November 10
November 03, 2023
Via ACCESSWIRE
News headline image
Biofrontera Inc. Announces $4.5 Million Registered Direct Offering Priced At-the-market Under NASDAQ Rules
October 31, 2023
Via ACCESSWIRE
News headline image
Biofrontera Inc. to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference
October 05, 2023
Via ACCESSWIRE
News headline image
Biofrontera Inc. Appoints Samantha Widdicombe to Support Commercial Relationships with Strategic Customer Accounts
August 29, 2023
Via ACCESSWIRE
News headline image
Biofrontera Inc. Announces Positive Results from Phase 1 Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz(R)
August 28, 2023
Via ACCESSWIRE
News headline image
Biofrontera Inc. to Report Second Quarter Financial Results on August 11, 2023
August 04, 2023
Via ACCESSWIRE
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap